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Abstract Arg82, a nuclear regulator of diverse cellular
processes in yeast, is an inositol polyphosphate kinase. Some
defects such as the regulation of arginine metabolism observed in
an arg82v, result from a lack of Mcm1 and Arg80 stability. We
show here that neither the kinase activity of Arg82 nor inositol
phosphates are required for the control of arginine metabolism.
Arg82 mutations keeping kinase active affect the expression of
arginine genes, whereas mutations in the kinase domain do not
impair this metabolic control. ß 2000 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Arg82/ArgRIII was ¢rst identi¢ed as one of the regulators
of the arginine metabolism in Saccharomyces cerevisiae [1]. A
mutation in ARG82 led to the loss of anabolic gene repression
and catabolic gene induction by arginine, impairing the
growth on ornithine as sole nitrogen source. However, dele-
tion of ARG82 impairs other cellular processes, such as mat-
ing, sporulation and growth at 37‡C [2]. More recently, two
groups showed that Arg82 phosphorylates inositol (1,4,5) tris-
phosphate (Ins(1,4,5)P3) to inositol (1,3,4,5) tetrakisphos-
phate (Ins(1,3,4,5)P4) and Ins(1,4,5,6)P4, both of which are
then converted by Arg82 to Ins(1,3,4,5,6)P5 [3^5]. Arg82 is
therefore an inositol tris- and tetrakisphosphate 3-/6-kinase
that will produce InsP6, InsP7 and InsP8 as end-products of
the inositol phosphate metabolism [4]. This is a unique feature
of the yeast enzyme, distinct from the mammalian Ins(1,4,5)P3
3-kinases that only phosphorylate Ins(1,4,5)P3 in Ins-
(1,3,4,5)P4 and share conserved sequences in their primary
structures [6].
Besides Arg82, three other regulatory factors Arg80/ArgRI,
Arg81/ArgRII and Mcm1 are required to ensure the coordi-
nation of arginine anabolic and catabolic gene expression in
response to arginine [1,7^9]. Arg80 and Mcm1 are members
of the MADS-box transcription factor family, and Arg81
which is a zinc cluster protein, is the sensor of arginine. These
three proteins interact and are su⁄cient to form a complex
with DNA (arginine boxes) when arginine is present [10].
Arg82 is not required for the formation of this complex pro-
vided that Arg80 and Mcm1 are present in su⁄cient amounts.
We have clearly shown that Arg82 associates with and stabil-
izes Arg80 and Mcm1 [11]. However, Odom et al. [5] pro-
posed a role for the inositol polyphosphate kinase activity
(Ipk2) of Arg82 in arginine regulation. According to these
authors, the Arg80^Arg81^Mcm1 transcriptional complex
with DNA would be inactive in the absence of Arg82 kinase
activity. This assumption was only based on growth data at
30‡C on ornithine as sole nitrogen source, obtained with a
strain devoid of phospholipase C or impaired in the Arg82
kinase activity [5]. However, in our hands, a plc1v strain grew
poorly on all media, and not only on ornithine. This
prompted us to reinvestigate the role of the Ipk2 activity of
Arg82 in the regulation of the arginine metabolism.
2. Materials and methods
2.1. Strains and media
Deletions were created in strain 27061b (ura3, trp1), derived from
the wild type strain 41278b. Escherichia coli strain XL1-Blue (Strata-
gene) was used for plasmid ampli¢cation.
All yeast strains were grown on minimal medium containing 3%
glucose, vitamins and mineral traces [12]. Nitrogen sources were
0.02 M (NH4)2SO4 (M. ammonia) or 1 mg per ml ornithine (M.
ornithine). Rich medium (YPD) contained 1% yeast extract, 1% bac-
topeptone and 2% glucose.
2.2. Construction of deletant strains
The long £anking homology strategy was used to perform deletions
of ARG82 and PLC1 genes [13,14]. A long £anking homology replace-
ment cassette was synthesized using a two-step polymerase chain re-
action (PCR) leading to the kanMX4 cassette £anked by about 500 bp
corresponding to the promoter and terminator regions of the target
genes. The DNA fragments containing the di¡erent cassettes were
used to transform yeast strain 27061b (ura3, trp1) on rich medium
plates containing 200 Wg/ml of geneticin. The correct targeting of the
deletions in G418r transformants was veri¢ed by PCR, using whole
cells as a source of DNA, and appropriate primers.
2.3. Plasmids
The wild type ARG82 gene was recloned on a pFL38 plasmid
(pUC19, ARS4, CEN6, URA3) [15]. A 1.85 kb BamHI^BamHI frag-
ment of ARG82 was synthesized by PCR using two oligonucleotides
RIII45 and RIII49 (Table 1) and either genomic wild type DNA, or
DNA from plasmid pMJ313 containing the mutated arg82W65R gene
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[16]. These fragments were inserted in the BamHI site of pFL38,
yielding plasmids pFV145 and pFV160, respectively. Plasmid
pQvRIII-1 containing the deletion of the C-terminal aspartate-rich
region (v282^303) was described in Qiu et al. [16]. GST^arg82v282^
303 fusion was constructed by synthesizing a 1 kb BamHI^BamHI
fragment by PCR from plasmid pQvRIII-1 using oligonucleotides
RIII21 and RIII39. GST refers to the glutathione S-transferase
E. coli gene. This fragment was inserted into the BamHI site of plas-
mid pGEX-5X-3 vector, expressing glutathione S-transferase, yielding
plasmid pFV182. To express gene PLC1 under the dependence of the
TPI promoter (triose phosphate isomerase) we inserted a 2.6 kb
EcoRI DNA fragment, corresponding to the entire PLC1 coding se-
quence, in the EcoRI site of plasmid pYX212 (TPI, URA3, 2W), yield-
ing plasmid pFV139. This EcoRI fragment was synthesized by PCR,
using genomic yeast DNA and oligonucleotides PLC1 and PLC2.
2.4. Creation of mutations in the ARG82 gene
Di¡erent oligonucleotides (Table 1) were used to create substitu-
tions by in vitro mutagenesis on double stranded DNA from plasmid
pFV145 (URA3, ARG82) using the Quick Change site-directed muta-
genesis kit from Stratagene. In this plasmid the following amino acid
changes, P127A, L129A, D131A, K133A and G135A, were achieved
using oligonucleotides RIII56^RIII57, RIII50^RIII51, RIII52^RIII53,
RIII47^RIII48 and RIII54^RIII55, respectively. The resulting mutant
plasmids were: pFV169 (arg82P127A), pFV147 (arg82L130A),
pFV148 (arg82D131A), pFV146 (arg82K133A), pFV149 (arg82-
G135A), pFV170 (GST^arg82P127A), pFV157 (GST^arg82L129A),
pFV158 (GST^arg82D131A) pFV156 (GST^arg82K133A) and
pFV159 (GST^arg82G135A).
All the wild type and mutated ARG82 genes were completely se-
quenced to ensure that the gene fusions were in frame and that no
error was introduced during the PCR procedure. Denatured double
stranded DNA used as template for DNA sequencing was prepared
using Qiagen columns. DNA was sequenced by the Sanger method
[17], oligonucleotides being used as primers.
2.5. Puri¢cation of GST^fusion proteins
Following transformation of E. coli XL1-Blue, induction of the
fusion proteins was achieved by addition of 500 WM isopropyl-L-D-
thiogalactopyranoside for 3 h at 37‡C. Bacterial pellets were resus-
pended in phosphate-bu¡ered saline (140 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 1.8 mM KH2PO4) containing a mixture of pro-
tease inhibitors, and sonicated on ice for 3 min. After centrifugation
(12 000 rpm, 15 min), puri¢cation was achieved as in Amar et al. [10].
2.6. Assays of enzyme activities
Ornithine carbamoyltransferase (OTCase) and arginase activities
were assayed as described previously [18]. Protein contents were de-
termined by the Folin method.
Ipk2 activity was measured at 10 WM Ins(1,4,5)P3, in the presence
of 1 mM EGTA, as reported in Takazawa et al. [19].
3. Results
3.1. Deletion of the PLC1 gene impairs cellular growth, but not
the regulation of arginine metabolism
PLC1 encodes phospholipase C that makes Ins(1,4,5)P3
from PtdIns(4,5)P2. Consequently, deletion of PLC1 deprives
the cells of the substrate of Arg82/Ipk2. To test whether ino-
sitol polyphosphates play a direct role in the control of argi-
nine metabolism, we deleted the PLC1 and the ARG82 genes
by replacing their complete coding sequences by the kanMX4
cassette, conferring resistance to geneticin. We compared the
growth rates of arg82v (03058c) and plc1v (03135a) strains on
M. ammonia or M. ornithine as sole nitrogen source, to the
growth rate of the wild type strain. As shown in Fig. 1,
growth of the plc1v strain was impaired to the same extent
on M. ammonia as well as on M. ornithine, and wild type
growth was restored when the strain was transformed with the
cognate PLC1 gene. In contrast, the deletion of ARG82 re-
duced cellular growth on M. ammonia and led to an absence
of growth on M. ornithine. These data indicated that Plc1 was
required to ensure a normal growth, and suggested that the
loss of Plc1 activity did not a¡ect the regulation of the argi-
nine metabolism. To con¢rm the growth data, we measured
the levels of OTCase, an anabolic enzyme, and of arginase, a
Table 1
Oligonucleotides used for ARG82 and PLC1 syntheses by PCR and for in vitro mutagenesis in ARG82 gene
Oligomer Length Sequence Modi¢cation
RIII45 30 CGCGGATCCCTTCCGGAAGCTTCTCTCCGC creation of a BamH1 site at position 3310
RIII49 29 CGCGGATCCAAGTTTGTAGCTCAAATTGC CS creation of a BamH1 site at position +1569
RIII21 30 GAAATTTTTTTCGGATCCATACGGTAAACA creation of a BamH1 site at position +4
RIII39 28 CGCGGATCCCTTCACCTCTCAATATATC CS creation of a BamH1 site at position +1086
RIII56 30 GGATTTAGTAAAGCGAATATACTTGATATA substitution of amino acid (aa) P127A
RIII57 30 TATATCAAGTATATTCGCTTTACTAAATCC CS substitution of aa P127A
RIII50 30 AAACCTAATATAGCAGATATAAAATTAGGC substitution of aa L130A
RIII51 30 GCCTAATTTTATATCTGCTATATTAGGTTT CS substitution of aa L130A
RIII52 30 CCTAATATACTTGCAATAAAATTAGGCAAA substitution of aa D131A
RIII53 30 TTTGCCTAATTTTATTGCAAGTATATTAGG CS substitution of aa D131A
RIII47 33 AATATACTTGATATAGCGTTAGGCAAAACTTTG substitution of aa K133A
RIII48 33 CAAAGTTTTGCCTAACGCTATATCAAGTATATT CS substitution of aa K133A
RIII54 30 GATATAAAATTAGCGAAAACTTTGTATGAT substitution of aa G135A
RIII55 30 ATCATACAAAGTTTTCGCTAATTTTATATC CS substitution of aa G135A
PLC1 27 CCGGAATTCAGGTCATTCACGCAGTGT creation of an EcoRI site at position 324
PLC2 27 CCGGAATTCATATGTGTATTTGGCCGG CS creation of an EcoRI site at position +2641
The altered nucleotides are indicated in bold. CS means complementary strand.
Fig. 1. E¡ect of deletions in ARG82 and PLC1 genes on cell
growth. 10-fold serial dilutions of cells were plated and incubated at
30‡C for 3 days on M. ammonia and M. ammonia+25 Wg/ml of
tryptophan, and M. ornithine+25 Wg/ml of tryptophan. Strains
27061b (ura3, trp1, taken as wild type), 03058c (ura3, trp1, arg82: :
kanMX4 = arg82v), and 03135a (ura3, trp1, plc1: :kanMX4 = plc1v)
are isogenic to strain 41278b. These strains were transformed with
the high copy plasmid pYX212 containing the URA3 marker and a
TPI promoter, and strain 03135a was also transformed with the
same plasmid in which the PLC1 gene was expressed from the TPI
promoter (pFV139).
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catabolic enzyme, from cells grown in the presence or absence
of arginine.
As shown in Fig. 2, the deletion of ARG82 abolished re-
pression of OTCase and induction of arginase by arginine,
whereas the levels of these enzymes in a plc1v strain were
comparable to those of the wild type strain. Thus the absence
of Ins(1,4,5)P3 did not a¡ect the expression of arginine co-
regulated genes, which argues against a direct role of Ins-
(1,4,5)P3 or one of its metabolites in this control.
3.2. Mutations in the putative inositol phosphate binding site of
Arg82 do not impair the regulation of the arginine
metabolism
As for the plc1v strain, Odom et al. [5] showed that a
mutation in the putative Ins(1,4,5)P3 binding of Arg82
(D131A) led to an absence of growth on M. ornithine, sug-
gesting that the Ipk2 activity was required to control arginine
metabolism. Since our data with the plc1v strain clearly
showed that the slower growth of that strain on M. ornithine
resulted from a general growth defect and not from an ab-
sence of arginine catabolic gene induction, we created a series
of mutations in the putative inositol phosphate binding site.
An alignment of the Ins(1,4,5)P3 binding site of Arg82 and rat
brain Ins(1,4,5)P3 3-kinase A is presented in Fig. 2. The ¢ve
residues conserved in these kinases (marked in bold) were
replaced by alanines. The di¡erent plasmids pFV145 (Arg82
wild type), pFV169 (arg82P127A), pFV147 (arg82L130A),
pFV148 (arg82D131A), pFV146 (arg82K133A), pFV149
(arg82G135A), pFV160 (arg82W65R) and pFV182
(arg82v282^303) were introduced in the strain O3058c (ura3,
trp1, arg82: :kanMX4). The mutation arg82W65R had been
selected in vivo for its impairment in arginine regulation and
we also tested the e¡ect of the deletion of the aspartate-rich
stretch present in the C-terminal end of Arg82 [1,16]. OTCase
and arginase activities were measured in extracts from the
di¡erent transformed strains, grown on M. ammonium with
or without arginine. As shown in Fig. 2, none of the muta-
tions created in the Ins(1,4,5)P3 binding site a¡ected the re-
pression of OTCase and the induction of arginase. In con-
trast, the mutation arg82W65R, used as a control, led to an
absence of repression and of induction. Similarly, the deletion
of the acidic-rich region also impaired the regulation of argi-
nine anabolic and catabolic enzymes.
3.3. Determination of the Ins(1,4,5)P3 kinase activities
Arg82 has been shown to contain a consensus sequence of
inositol phosphate kinases [3] which was localized in the
Ins(1,4,5)P3 binding site. Structural identi¢cation of the
Ins(1,4,5)P3 binding domain of mammalian Ins(1,4,5)P3 3-ki-
nase A enabled the identi¢cation of a crucial lysine residue
(K262) that was essential for Ins(1,4,5)P3 binding [20]. This
residue was conserved in Arg82 (Fig. 2). Arg82 wild type and
the di¡erent mutants were assayed for Ins(1,4,5)P3 kinase
activity at 10 WM Ins(1,4,5)P3. All mutants tested, except
arg82L130A, had lost partially or completely the Ins(1,4,5)P3
kinase activity. The deletion of the acidic region in arg82
resulted in a fully active enzyme (Fig. 3). We concluded that
Fig. 2. E¡ect of PLC1 deletion and of point mutations in ARG82
on the control of arginine metabolism. The strain 03135a
(plc1: :kanMX4, ura3, trp1) transformed with plasmid pFL38, and
the strain 03058c (arg82: :kanMX4, ura3, trp1) transformed with the
following plasmids, pFL38 (pURA3), pFV145 (p-ARG82 wild type),
pFV169 (p-arg82P127A, pFV147 (p-arg82L130A), pFV148 (p-arg82-
D131A), pFV146 (p-arg82K133A), pFV149 (p-arg82G135A),
pFV160 (p-arg82W65R) and pFV182 (p-arg82v282^303), were
grown on minimal medium supplemented with 25 Wg/ml tryptophan,
with or without 1 mg/ml arginine. The repression factor of OTCase
corresponds to the ratio between the OTCase speci¢c activity of the
arg82v mutant strain grown on M. ammonium and the OTCase
speci¢c activity of the di¡erent strains grown on M. ammonium
plus arginine. The induction factor of arginase corresponds to the
ratio between the arginase speci¢c activity of the di¡erent strains
grown on M. ammonium plus arginine and the arginase speci¢c ac-
tivity of the arg82v strain grown on M. ammonium. The open bar
represents the Arg82 protein with the localization of the di¡erent
mutations analyzed, and amino acid alignment of the Ins(1,4,5)P3
binding site of Arg82 and rat brain Ins(1,4,5)P3 3-kinase A. The
numbers correspond to the positions of the amino acids in the pro-
teins. The well conserved residues, which were replaced by alanine
in Arg82 are indicated in bold.
Fig. 3. E¡ect of point mutations in GST^Arg82 on Ipk2 activity.
Since the production of the various GST constructs was not compa-
rable, Ins(1,4,5)P3 kinase activity was expressed relatively to the
amounts of enzyme applied onto the gel and stain by Coomassie
blue. Activities are means of triplicates þ S.D.
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the regulation of arginine anabolic and catabolic genes is not
related to Ins(1,4,5)P3 kinase activities of the various GST^
Arg82 recombinant proteins produced in E. coli.
3.4. E¡ect of point mutations in ARG82 gene on cell growth
Since some of the mutants were impaired in Ins(1,4,5)P3
kinase activity, we tested whether these strains were a¡ected
in growth. This is the major distinction between our study and
that of York’s group. In their study, both the arg82v strain
transformed with the plasmid expressing arg82D131A and the
plc1v strain were growth-impaired only on ornithine as sole
nitrogen source [5]. In our hands, the strain expressing arg82-
D131A protein grew very poorly on M. ammonia as well as
on M. ornithine (Fig. 4). Two other changes, K133A and
W65R, also reduced the growth on M. ammonia, but only
the change W65R abolished completely the growth on M.
ornithine. In contrast, the deletion of the acidic-rich region
reduced the growth on M. ornithine but not on M. ammonia.
Three other changes, P127A, L129A and G135A, had no sig-
ni¢cant e¡ect.
4. Discussion
The recent discovery that Arg82 is an Ipk2 raised the ques-
tion of a role of inositol phosphates in transcription [4,5,21].
Many of the defects observed in an arg82 deletant result from
a strong decrease in the amount and stability of Mcm1, an
essential transcription regulator of mating, G1 and G2/M
phase transition, minichromosome maintenance and arginine
metabolism. However, the sporulation defect and absence of
growth at 37‡C of an arg82 deleted strain, are not linked to a
low Mcm1 level. For these cellular processes (Mcm1-inde-
pendent), Arg82 could associate and stabilize other regulators.
Whether the kinase activity of Arg82 is required for all the
networks in which this protein is involved is still open. York’s
group attempted to prove that the kinase activity of Arg82
was required for the regulation of arginine metabolic genes.
They showed that the DNA binding activity of the Arg80^
Arg81^Mcm1 regulatory complex was una¡ected in a strain
lacking Plc1 activity or in a strain lacking Arg82 kinase ac-
tivity. These data argued strongly against the involvement of
inositol phosphates in the regulation of the arginine metabo-
lism. However, these two strains showed a growth impairment
when ornithine was used as sole nitrogen source, which is a
major characteristic of lack of regulation of the arginine ca-
tabolic genes. Odom et al. [5] proposed that the regulatory
Arg80^Arg81^Mcm1 complex was inactive in the absence of
inositol phosphate kinase activity, even bound to the target
promoters. We show here that the growth defect observed in
the two mutant strains described above is general and not
restricted to the nitrogen source requiring expression of argi-
nine catabolic genes. Moreover, repression of the anabolic
genes and induction of the catabolic genes by arginine are
not impaired in a vplc1 strain, nor in strains which have
lost arg82 kinase activity. In contrast, mutations in Arg82,
keeping the kinase active, had lost the arginine regulation.
The kinase activity of Arg82 is thus dispensable to regulate
arginine metabolism, in response to this amino acid. However
since Arg82 is pleiotropic, it is likely that other functions
could depend on this kinase activity. We observed here that
mutations in the Ins(1,4,5)P3 binding site signi¢cantly reduced
the growth of these strains, although there was no simple
correlation between the growth rates and the kinase activities
of recombinant GST^arg82 proteins. To further establish the
role of inositol phosphates in the di¡erent cellular processes
controlled by Arg82 protein, it would be interesting to mea-
sure the intracellular variation of these metabolites, under
di¡erent growth conditions and in di¡erent mutant strains.
It would also be of interest to measure Arg82 kinase activity
in yeast extracts to determine if this activity is regulated by
means of protein^protein interactions, as shown for the mam-
malian Ins(1,4,5)P3 3-kinases, typical calmodulin sensitive en-
zymes.
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